SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:148072930"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:148072930" > Making Sense of Pat...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Unterholzner, J (author)

Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-07-03
  • Oxford University Press (OUP),2021

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:148072930
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:148072930URI
  • https://doi.org/10.1093/ijnp/pyab037DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The improvement of experimental models for disorders requires a constant approximation towards the dysregulated tissue. In psychiatry, where an impairment of neuronal structure and function is assumed to play a major role in disease mechanisms and symptom development, this approximation is an ongoing process implicating various fields. These include genetic, animal, and post-mortem studies. To test hypotheses generated through these studies, in vitro models using non-neuronal cells such as fibroblasts and lymphocytes have been developed. For brain network disorders, cells with neuronal signatures would, however, represent a more adequate tissue. Considering the limited accessibility of brain tissue, research has thus turned towards neurons generated from induced pluripotent stem cells as well as directly induced neurons, cerebral organoids, and olfactory neuroepithelium. Regarding the increasing importance and amount of research using these neuronal cells, this review aims to provide an overview of all these models to make sense of the current literature. The development of each model system and its use as a model for the various psychiatric disorder categories will be laid out. Also, advantages and limitations of each model will be discussed, including a reflection on implications and future perspectives.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Millischer, VKarolinska Institutet (author)
  • Wotawa, C (author)
  • Sawa, A (author)
  • Lanzenberger, R (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:The international journal of neuropsychopharmacology: Oxford University Press (OUP)24:10, s. 759-7751469-51111461-1457

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view